White Paper

Pharmacy Services In A Phase I Clinical Research Unit

Source: Worldwide Clinical Trials

By Andrea Hamilton, Pharm.D., Sherilyn Adcock, Ph.D., George Atiee, M.D., John Sramek, Pharm.D., Jeremy Kuhn, Pharm.D.

Pharmacy Services In A Phase I Clinical Research Unit

Because of the increasing demands for shorter timetables in drug development, sophisticated pharmacodynamics assessments and biomarkers have become more commonplace in Phase I studies as of late. This white paper discusses the role of the pharmacy in a modern day Phase I clinical research unit and its role in understanding the safety and pharmacology of a drug before Phase II can begin.